ACM
ENFN

Ararat Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Ararat Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,261,199
Closed -$14.1M – 21
2025
Q1 		$14.1M Sell
1,261,199
-1,080,730
-46% -$11.9M 6.88% 6
2024
Q4 		$24.1M Sell
2,341,929
-231,993
-9% -$2.24M 9.63% 2
2024
Q3 		$24.4M Sell
2,573,922
-782,811
-23% -$6.75M 8.43% 2
2024
Q2 		$28.6M Buy
3,356,733
+300,535
+10% +$2.75M 8.78% 2
2024
Q1 		$28.3M Buy
3,056,198
+472,783
+18% +$4.16M 8.03% 3
2023
Q4 		$25.1M Buy
2,583,415
+216,870
+9% +$2.03M 7.26% 5
2023
Q3 		$21.2M Sell
2,366,545
-68,761
-3% -$653K 7.22% 6
2023
Q2 		$27.3M Buy
2,435,306
+159,418
+7% +$1.41M 9.11% 2
2023
Q1 		$23.9M Sell
2,275,888
-54,869
-2% -$605K 7.62% 4
2022
Q4 		$22.5M Buy
2,330,757
+560,577
+32% +$6.31M 7.51% 6
2022
Q3 		$21.8M Sell
1,770,180
-441,940
-20% -$5.39M 9.14% 3
2022
Q2 		$22.6M Buy
2,212,120
+302,295
+16% +$3.34M 8.12% 4
2022
Q1 		$24.3M Buy
1,909,825
+1,023,180
+115% +$15.6M 7.77% 4
2021
Q4 		$18.6M Buy
+886,645
New +$17.9M 5.84% 9

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ararat Capital Management's ENFN Position: Q2 2025 in Review

Ararat Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,261,199 shares — an estimated $14.1M sold.

Ararat Capital Management first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $28.6M in Q2 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Ararat Capital Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Ararat Capital Management sold 1,261,199 Enfusion, Inc. shares in Q2 2025, an estimated $14.1M.
  • Ararat Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Ararat Capital Management's Enfusion, Inc. position peaked at $28.6M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Ararat Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.